Literature DB >> 31367585

Blastic Transformation of a Mantle Cell Lymphoma Presenting as an Enlarging Unilateral Orbital Mass.

Matthew A De Niear1, John P Greer2, Adam Seegmiller3, Louise A Mawn4,5.   

Abstract

Mantle cell lymphoma (MCL) is an uncommon form of non-Hodgkin lymphoma predominantly affecting male individuals of advanced age. Approximately 1-9% of cases of lymphoma affecting the orbital and ocular adnexal regions are attributed to MCL. We describe the case of a 65-year-old man with a 24-year history of MCL with initial remission followed by multiple relapses who presented with acute-onset binocular diplopia and proptosis of the left eye. Subsequent imaging demonstrated a new left superior orbital mass. Biopsy of the mass revealed two clonally related, yet distinct cellular components demonstrating the classical mantle cell morphology and large cells that appeared to have transformed to the blastoid variant of MCL. Transformation of classical MCL to the blastoid variant of MCL is rare, with few reports in the literature. The blastoid variant of MCL tends to be aggressive and associated with a poor prognosis. The case we describe represents perhaps the first report of MCL transformation observed in the orbit.

Entities:  

Keywords:  Blastic transformation; Blastoid variant of mantle cell lymphoma; Mantle cell lymphoma; Ocular adnexa; Orbital lymphoma

Year:  2018        PMID: 31367585      PMCID: PMC6615325          DOI: 10.1159/000492832

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  30 in total

1.  Blastic transformation of mantle cell lymphoma: genetic evidence for a clonal link between the two stages of the tumour.

Authors:  T László; A Matolcsy
Journal:  Histopathology       Date:  1999-10       Impact factor: 5.087

2.  The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma.

Authors:  Tiemo Katzenberger; Celine Petzoldt; Sylvia Höller; Uwe Mäder; Jörg Kalla; Patrick Adam; M Michaela Ott; Hans Konrad Müller-Hermelink; Andreas Rosenwald; German Ott
Journal:  Blood       Date:  2006-04-15       Impact factor: 22.113

3.  Lymphoma of the ocular adnexa: A study of 353 cases.

Authors:  Judith A Ferry; Claire Y Fung; Lawrence Zukerberg; Mark J Lucarelli; Robert P Hasserjian; Frederic I Preffer; Nancy L Harris
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

4.  A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors.

Authors:  N S Andersen; M K Jensen; P de Nully Brown; C H Geisler
Journal:  Eur J Cancer       Date:  2002-02       Impact factor: 9.162

Review 5.  Mantle-cell lymphoma.

Authors:  I Barista; J E Romaguera; F Cabanillas
Journal:  Lancet Oncol       Date:  2001-03       Impact factor: 41.316

6.  Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.

Authors:  M Bernard; R Gressin; F Lefrère; B Drénou; B Branger; S Caulet-Maugendre; P Tass; N Brousse; F Valensi; N Milpied; L Voilat; A Sadoun; C Ghandour; M Hunault; R Leloup; L Mannone; O Hermine; T Lamy
Journal:  Leukemia       Date:  2001-11       Impact factor: 11.528

7.  Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.

Authors:  Markus Tiemann; Carsten Schrader; Wolfram Klapper; Martin H Dreyling; Elias Campo; Andrew Norton; Francoise Berger; Philip Kluin; German Ott; Stephano Pileri; Ennio Pedrinis; Alfred C Feller; Hartmut Merz; Dirk Janssen; Martin L Hansmann; Han Krieken; Peter Möller; Harald Stein; Michael Unterhalt; Wolfgang Hiddemann; Reza Parwaresch
Journal:  Br J Haematol       Date:  2005-10       Impact factor: 6.998

8.  Mantle cell lymphoma in the ocular adnexal region.

Authors:  Audrey Looi; Randy D Gascoyne; Mukesh Chhanabhai; Joseph M Connors; Jack Rootman; Valerie A White
Journal:  Ophthalmology       Date:  2005-01       Impact factor: 12.079

Review 9.  Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.

Authors:  Pedro Jares; Dolors Colomer; Elias Campo
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

10.  Central nervous system involvement in mantle cell lymphoma.

Authors:  A Ferrer; F Bosch; N Villamor; M Rozman; F Graus; G Gutiérrez; S Mercadal; E Campo; C Rozman; A López-Guillermo; E Montserrat
Journal:  Ann Oncol       Date:  2007-10-24       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.